A peptide inhibitor of corticotropin-releasing factor binding protein (CRFBP) that displaces CRF from CRFBP, and suppresses body weight gain and increases motor activity in obese rats in vivo.
CAT No: R1023
CAS No:120066-38-8
Synonyms/Alias:CRF (6-33) (HUMAN, RAT);120066-38-8;MFCD00671436;Crf(6-33)(human,rat);DTXSID80745604;PUBCHEM_71308685;AKOS024456702;FC109011;PD086345;CRF (6-33) (human, rat) (H-L-Ile-L-Ser-L-Leu-L-Asp-L-Leu-L-Thr-L-Phe-L-His-L-Leu-L-Leu-L-Arg-L-Glu-L-Val-L-Leu-L-Glu-L-Met-L-Ala-L-Arg-L-Ala-L-Glu-L-Gln-L-Leu-L-Ala-L-Gln-L-Gln-L-Ala-L-His-L-Ser-OH);H-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-OH; H-ISLDLTFHLLRE VLEMARAEQLAQQAHS-OH;
2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
4. Myotropic activity of allatostatins in tenebrionid beetles
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More